CUL4B

Cullin-4B · Q13620 · CUL4B on Sugi Atlas →

0 patent compounds predicted against CUL4B, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CUL4B by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Phase II Study of Vandetanib in Individuals With Kidney Cancer PHASE2COMPLETED
Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers PHASE2NOT_YET_RECRUITING
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease EARLY_PHASE1RECRUITING
Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma EARLY_PHASE1RECRUITING
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma nanCOMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
ADAPT: Efficacy of a Dietary Supplement During and After Exercise nanCOMPLETED
The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin nanUNKNOWN
Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease? nanUNKNOWN
Drivers of Hypoxia-induced Angiogenesis in Tumor Development nanUNKNOWN
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System nanCOMPLETED
Angelman Syndrome Natural History Study nanRECRUITING
Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease nanCOMPLETED
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants nanRECRUITING
DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. nanCOMPLETED
Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC) nanUNKNOWN
DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study nanRECRUITING
Characterization of Angelman Syndrome nanCOMPLETED
Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients nanRECRUITING
Ohio Colorectal Cancer Prevention Initiative nanCOMPLETED
Value of MicroRNA30a in Philadelphia Positive Leukemic Patients nanUNKNOWN
Italian Angelman Syndrome Registry nanCOMPLETED
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders nanRECRUITING
Testing of NBIA Genes: Analysis of Genetic Heterogeneity and Validation of Mitochondrial Markers for Assessing Causality of Sequence Variants. nanCOMPLETED
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping nanUNKNOWN
Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1 nanRECRUITING
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
18F-FDG PET/TC in TIR3A e TIR3B nanENROLLING_BY_INVITATION

Related proteins — ESM-2 sequence neighbours (a CUL4B binder may also engage these)

ProteinNameSimilarity
A2A432 0.995 A2A432 →
CUL4A Cullin-4A 0.975 landscape →
Q3TCH7 0.967 Q3TCH7 →
F1LSG8 0.945 F1LSG8 →
Q8CI71 0.945 Q8CI71 →
Q6NRT5 0.944 Q6NRT5 →
Q96JG6 0.943 Q96JG6 →
Q5NVP9 0.943 Q5NVP9 →
GPS1 COP9 signalosome complex subunit 1 0.943 landscape →
Q5ZKV9 0.943 Q5ZKV9 →
Q6AYU1 0.943 Q6AYU1 →
Q99LD4 0.942 Q99LD4 →
P97834 0.941 P97834 →
Q5ZML9 0.940 Q5ZML9 →
Q5XIT1 0.940 Q5XIT1 →
DHX9 ATP-dependent RNA helicase A 0.940 landscape →
Q5R874 0.939 Q5R874 →
Q6PER3 0.938 Q6PER3 →
P17427 0.936 P17427 →
P60762 0.936 P60762 →
Q9UPY8 0.936 Q9UPY8 →
MORF4L1 Mortality factor 4-like protein 1 0.936 landscape →
P18484 0.936 P18484 →
Q6PFJ9 0.935 Q6PFJ9 →
Q9Z1K5 0.934 Q9Z1K5 →
A2VEA3 0.934 A2VEA3 →
Q32NS4 0.934 Q32NS4 →
EXOC1 Exocyst complex component 1 0.933 landscape →
Q8TAG9 0.932 Q8TAG9 →
Q8R3S6 0.931 Q8R3S6 →